Showing results (11-20 of 559) with videos related to
Sort By:
Pageof 56
Chemical Society Reviews|July 6, 2022
Lanthanide porphyrinoids as molecular theranosticsGuo-Qing Jin, Calvin V Chau, Jonathan F Arambula, et al.Chemical Society Reviews|December 22, 2018
Hypoxia-targeted drug deliveryAmit Sharma, Jonathan F Arambula, Seyoung Koo, et al.Chemical Science|June 24, 2021
Covalent and non-covalent albumin binding of Au(i) bis-NHCs <i>via</i> post-synthetic amide modificationSajal Sen, Mark W Perrin, Adam C Sedgwick, et al.Inorganic Chemistry|April 6, 2013
Recent developments in texaphyrin chemistry and drug discoveryChristian Preihs, Jonathan F Arambula, Darren Magda, et al.Chemical Society Reviews|January 31, 2022
Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and futureSajal Sen, Miae Won, Matthew S Levine, et al.Journal of the American Chemical Society|September 12, 2019
Targeting Heterogeneous Tumors Using a Multifunctional Molecular ProdrugAmit Sharma, Min-Goo Lee, Miae Won, et al.Chem|September 1, 2020
Mitochondrial relocation of a common synthetic antibiotic: A non-genotoxic approach to cancer therapyKyoung Sunwoo, Miae Won, Kyung-Phil Ko, et al.Molecular Pharmaceutics|October 29, 2025
Profiling the Preclinical Pharmacokinetics and Biodistribution of a Platinum(IV)-Based Oxaliplatin Prodrug OxaliTEX and Their Significance to Antitumor ResponseGuangan He, Gregory D Thiabaud, Kathryn A Shelton, et al.Chemical Communications (Cambridge, England)|June 11, 2020
Toward multifunctional anticancer therapeutics: post-synthetic carbonate functionalisation of asymmetric Au(i) bis-N-heterocyclic carbenesSajal Sen, Mark W Perrin, Adam C Sedgwick, et al.Chem|January 20, 2025
Overcoming Drug Resistance by Targeting Cancer Bioenergetics with an Activatable ProdrugAmit Sharma, Min-Goo Lee, Hu Shi, et al.Pageof 56